Search

Your search keyword '"Roland Jahns"' showing total 4 results
Start Over "Roland Jahns" Publication Year Range This year
4 results on '"Roland Jahns"'

2. German Society for Clinical Chemistry and Laboratory Medicine – areas of expertise: Division reports from the German Congress of Laboratory Medicine 2022 in Mannheim, 13–14 October 2022.

Author

Nauck, Matthias, Holdenrieder, Stefan, Klein, Hanns-Georg, Findeisen, Peter, Winter, Christof, Ceglarek, Uta, Petersmann, Astrid, Klouche, Mariam, Lichtinghagen, Ralf, Biemann, Ronald, Adler, Jakob, Streichert, Thomas, von Meyer, Alexander, Wieland, Eberhard, Hofmann, Walter, Aufenanger, Johannes, Orth, Matthias, Shipkova, Maria, Bidlingmaier, Martin, and Birschmann, Ingvild

Subjects
MEDICAL laboratory science, METABOLOMICS, MOLECULAR pathology, CLINICAL chemistry, PROTEOMICS, BIOINFORMATICS, CLINICAL competence, MASS spectrometry, MEDICAL informatics
Abstract

The programme of the German Congress for Laboratory Medicine 2022 was essentially designed by the divisions of the German Society for Clinical Chemistry and Laboratory Medicine (DGKL). Almost all chairpersons of the divisions organised a 90-min symposium on current topics, i.e. conceptualised the symposia and invited speakers. For this article all chairpersons summarised the lectures that were given within the symposia. The DGKL's work is structured into 5 areas of expertise: Molecular Diagnostics, Learning & Teaching, Quality & Management, Laboratory & Diagnostics and Biobanks & Informatics. The areas of expertise are in turn subdivided into divisions. About the history of the establishment of this new structure within the DGKL you can find information in the editorial of this issue. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

3. Findings on Obesity, Fitness and Wellness Detailed by Investigators at University of Wurzburg (From "contraindicated" To "first Line" - Current Mechanistic Insights Beyond Canonical O-receptor Signaling).

Subjects
OBESITY, SIGNALS & signaling, REPORTERS & reporting, ELECTRONIC records
Abstract

A recent study conducted at the University of Wurzburg in Germany has examined the use of beta-blockers in the treatment of cardiovascular diseases. The researchers found that while there are many licensed compounds available, only four are commonly used for heart failure therapy. The study also highlighted the importance of considering various characteristics and potential side effects when prescribing beta-blockers for heart failure and other related conditions. The research provides valuable insights into the mechanisms and potential benefits of beta-blocker therapy. [Extracted from the article]

Published
2024

4. Findings on Obesity, Fitness and Wellness Detailed by Investigators at University of Wurzburg (From 'contraindicated' To 'first Line' - Current Mechanistic Insights Beyond Canonical O-receptor Signaling)

Subjects
Obesity -- Research -- Complications and side effects, Physical fitness -- Research, Health
Abstract

2024 JUN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Obesity, Fitness and Wellness have been published. According [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results